Gaza health system ‘extremely fragile' as aid point killings increase: ICRC
Gaza's healthcare system is 'extremely fragile' amid the ongoing Israeli war, the International Committee of the Red Cross (ICRC) has warned.
The organisation said in a statement on Sunday that the enclave's hospitals are in urgent need of protection and reinforcement amid Israel's continued bombardment and blockade. It added that the system is facing growing pressure due to increasing casualty rates from Israeli attacks at aid points.
'In the last two weeks, the Red Cross Field Hospital in Rafah has had to activate its mass casualty incident procedure 12 times, receiving high numbers of patients with gunshot and shrapnel wounds,' ICRC said in a statement on X on Sunday.
'An overwhelming majority of patients from the recent incidents said they had been trying to reach assistance distribution sites,' it continued.
Hundreds of Palestinians have been killed by Israeli fire around aid distribution sites operated by the US- and Israel-backed Gaza Humanitarian Foundation (GHF) since it launched on May 27.
The organisation ousted the United Nations and other independent agencies from the aid distribution effort following an 11-week blockade of the enclave that prompted numerous warnings that many of Gaza's people now face famine.
Gaza's Government Media Office reported on Sunday that the death toll from events centred on the GHF aid sites had risen to 125. A further 736 are reported to have been wounded, with nine missing.
The Hamas-run office said 13 people were killed and 153 injured in the latest attacks. Israeli forces were reported to have opened fire on civilians gathered near aid distribution centres east of Rafah and Wadi Gaza Bridge, in central Gaza.
Witness Abdallah Nour al-Din told the AFP news agency that 'people started gathering in the al-Alam area of Rafah' in the early morning.
'After about an hour and a half, hundreds moved towards the site and the army opened fire,' he said.
The Israeli military said it fired on people who 'continued advancing in a way that endangered the soldiers' despite warnings.
A GHF statement said there had been no incidents 'at any of our three sites' on Sunday.
The Red Cross also expressed concern that the intensifying conflict is putting the enclave's few functional medical facilities at risk.
'Recent days have seen an increase in hostilities around the few remaining and functional hospitals,' it said in the statement.
'This has made patient transfers between facilities increasingly challenging, and in many cases, patients cannot receive the intensive or specialized care they require.'
The ICRC warned that further loss of life is inevitable without urgent action and called for the protection of healthcare infrastructure and personnel.
'It requires taking all feasible steps to support their work, ensure their safety, and guarantee that they are not deprived of vital resources needed to carry out their work.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
diaMentis selected by Dassault Systèmes to join an exclusive group of innovative companies in the 3DEXPERIENCE Lab accelerator program
PARIS, June 12, 2025 /CNW/ - diaMentis, a company developing an innovative diagnostic support technology in mental health, recognized by the U.S. Food and Drug Administration (FDA) as a scientific breakthrough, has recently been selected by Dassault Systèmes to join its prestigious 3DEXPERIENCE Lab accelerator program. This unique program provides a hand-picked group of startups access to cutting-edge technological tools and resources to support the development of breakthrough solutions to today's global challenges. The latest results achieved with diaMentis' various patented innovations were recently published in the renowned scientific journal Biomedical Signal Processing and Control. These clinical outcomes, following the first interim analysis (IA1), demonstrate unprecedented performance levels in identifying biological markers specific to bipolar I disorder and schizophrenia. "Being selected by Dassault Systèmes for the 3DEXPERIENCE Lab represents a further recognition from a globally respected organization. This partnership will allow us to optimize our industrial development by leveraging their 3DEXPERIENCE platform and the expertise of their technology and health specialists," said Bernard Guimont, Vice President, Chief Financial Officer and Head of Partnerships at diaMentis. diaMentis is in the final stages of developing a Software as a Medical Device (SaMD) which, once approved, will help clinicians diagnose and treat mental illnesses, such as schizophrenia and bipolar I disorder, more quickly and effectively, using an objective and innovative approach. "We believe our technological platform, which uses High-Density Retinal Signal, has the potential to impact not only psychiatric disorders, but also non-psychiatric and neurological conditions," said Normand Tremblay, Co-founder and CEO of diaMentis. Mr. Tremblay adds: "The social and economic burden of these illnesses is astronomical and places tremendous financial pressure on healthcare systems worldwide. Once approved, diaMentis' technology will not only help save and improve lives, but also significantly enhance the efficiency of care delivery." About diaMentisdiaMentis was founded based on research conducted at Laval University and holds intellectual property rights related to the analysis of retinal signals. The company has been granted patents in the U.S. and Canada and has additional patents pending in several other countries. With its increasingly robust scientific results and in order to complete its regulatory process, diaMentis is currently seeking US$10M in short-term financing to finalize its clinical validation study at clinical sites across the U.S. and Canada. View original content to download multimedia: SOURCE diaMentis View original content to download multimedia: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
US FDA approves UroGen's bladder cancer drug
By Padmanabhan Ananthan and Kamal Choudhury (Reuters) -The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing an alternative treatment as opposed to traditional surgical procedures. U.S.-listed shares of the Israel-based company were up about 50% in afternoon trading. The approval follows a late-stage trial with 223 patients, in which 78% of the participants showed a complete response, meaning all signs of cancer disappeared in response to the treatment. The drug, branded Zusduri, will be the first to get approval to treat a type of bladder cancer that has not spread beyond the inner layers of the organ. The disease primarily affects older population. Scotiabank analyst George Farmer called the decision a "major positive outcome," noting that regulators were "moved by the quality of the clinical trial results, despite lack of solid randomized data". The FDA appreciated the non-surgical treatment option, describing it as "a huge win for patients with recurrent low-grade tumors" as it involves "a simple drug instillation in a doctor's office," Farmer added. Zusduri is a gel-based formulation that keeps chemotherapy in the bladder for a longer duration, aiming to reduce tumor recurrence and avoid repeated surgeries. UroGen said it expects the treatment to be available in the U.S. on or around July 1. Last month, an FDA advisory panel narrowly opposed approval of the drug citing concerns that a single arm study for efficacy might not be enough to indicate sustained benefits. The panel warned that such precedents could be problematic given existing surgical alternatives. The disease, a type of non-muscle invasive bladder cancer, affects about 82,000 people in the U.S. each year, with around 59,000 experiencing a recurrence, according to UroGen. Current standard-of-care treatments include surgical procedures such as transurethral resection of bladder tumor, in which doctors insert a thin tube through the urethra to remove the tumor.
Yahoo
5 hours ago
- Yahoo
Over 100 reported killed in Gaza in 24 hours as telecoms go down
More than 100 people were reported killed in Israeli strikes on Gaza within 24 hours, as deadly incidents near aid distribution sites and a major communications outage deepened the crisis in the war-shattered Palestinian territory on Thursday. The Health Ministry in Gaza, controlled by Hamas, reported 103 deaths and 427 injuries in the past day alone. The ministry does not distinguish between civilians and combatants, and the figures could not be independently verified. Since the start of the war on October 7, 2023, which was triggered by a Hamas-led attack on southern Israel that killed around 1,200 people and saw more than 250 taken hostage, more than 55,200 people have been killed in Gaza and over 127,800 injured, according to the ministry. Palestinians reported that Israeli forces opened fire near aid distribution positions, while a humanitarian foundation said Hamas launched a deadly attack on its staff. The Palestinian news agency WAFA said at least 13 people were killed and around 200 injured at an aid centre in the Netzarim Corridor in central Gaza. The Hamas-run Health Ministry confirmed the incident, but put the toll at 10 dead and at least 120 wounded. Separately, WAFA reported five more deaths in the Sudaniya area north-west of Gaza City, where people were waiting for food assistance. The Israeli military has not commented on the incidents. The Gaza Humanitarian Foundation (GHF), supported by Israel and the United States, began distributing aid last month following a near three-month Israeli blockade. The initiative aims to prevent Hamas from diverting aid, according to Israeli officials. However, the operation has drawn criticism from the UN and humanitarian organizations, who cite safety and access concerns. The GHF said that a Hamas attack on one of its staff buses killed eight Palestinian employees and injured several others on Wednesday evening. The team was en route to a distribution centre west of Khan Younis in southern Gaza. The foundation stated that some employees may have been taken hostage and that it was still gathering information. "These were aid workers. Humanitarians. Fathers, brothers, sons, and friends," GHF said, condemning what it called a "heinous and deliberate attack." The organization urged the international community to hold Hamas accountable, saying its staff had been targeted simply for delivering food to Palestinians. WAFA, citing medical sources, reported that 224 people have been killed and over 1,850 injured around aid distribution points since May 27. 'The points have become traps for mass killings,' the agency said. Communications blackout adds to chaos Also on Thursday, Gaza's last functioning fibre-optic network was damaged in an attack, resulting in a complete outage of internet and landline services, according to the Palestinian Telecommunications Authority. WAFA said the blackout would have severe humanitarian and social consequences and called for immediate restoration. Telecommunications have been repeatedly disrupted during the conflict, hampering relief coordination and civilian communication. Israel has been engaged in a sustained military campaign in Gaza for 20 months, with the stated goal of eliminating Hamas and securing the release of remaining hostages. A new major ground offensive was launched nearly a month ago. The campaign has drawn international criticism, including from Israel's close allies, over the mounting civilian toll and the humanitarian situation on the ground.
